First Isolation of bla _IMI-2 in an Enterobacter cloacae Clinical Isolate from China

This publication has 12 references indexed in Scilit:

• Carbapenemase-producingEnterobacteriaceae, U.S. Rivers
  Emerging Infectious Diseases, 2005
• Outbreak of Klebsiella pneumoniae Producing a New Carbapenem-Hydrolyzing Class A β-Lactamase, KPC-3, in a New York Medical Center
  Antimicrobial Agents and Chemotherapy, 2004
• Acquired Carbapenem-Hydrolyzing Beta-Lactamases and their Genetic Support
  Current Pharmaceutical Biotechnology, 2002
• Emerging carbapenemases in Gram-negative aerobes
  Clinical Microbiology & Infection, 2002
• Identification of a Plasmid Encoding SHV-12, TEM-1, and a Variant of IMP-2 Metallo-β-Lactamase, IMP-8, from a Clinical Isolate of Klebsiella pneumoniae
  Antimicrobial Agents and Chemotherapy, 2001
• Molecular and Biochemical Characterization of VEB-1, a Novel Class A Extended-Spectrum β-Lactamase Encoded by an Escherichia coli Integron Gene
  Antimicrobial Agents and Chemotherapy, 1999
• Characterization of IMI-1 beta-lactamase, a class A carbapenem-hydrolyzing enzyme from Enterobacter cloacae
  Antimicrobial Agents and Chemotherapy, 1996
• A functional classification scheme for beta-lactamases and its correlation with molecular structure
  Antimicrobial Agents and Chemotherapy, 1995
• Analysis of a carbapenem-hydrolyzing class A beta-lactamase from Enterobacter cloacae and of its LysR-type regulatory protein.
  Proceedings of the National Academy of Sciences, 1994
• Genetic and DNA sequence analysis of the kanamycin resistance transposon Tn903.
  Proceedings of the National Academy of Sciences, 1980